A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

NCT06088017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: CKD-391(2)
DRUG: CKD-331, D337

Sponsor

Chong Kun Dang Pharmaceutical